The Relationship Between NK Cell and Graves' Disease
NCT04135573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-04-14
Summary
Graves' disease (GD) is one of organ specific autoimmune diseases, the pathogenesis is not elucidated.Natural Killer (Natural Killer, NK) cells is a kind of important immune regulator, several abnormalities of NK cell function and number in GD patients have been described in the investigators' previous study. It is remain unclear whether the NK cell disfunction is a consequence of GD.Based on the investigators' previous study, the investigators plan to monitor NK cell function in participants in the whole course of disease, analyze the association with relevant factors, such as thyroid function, immune state or treatment,to find out influences of thyroid hormones and thyroid receptor antibody affecting the function of NK cell. The investigators will reveal whether the disfunction of NK cell secondary to GD abnormal thyroid function and/or immune disorders, and realize the mechanics.
Conditions
- Graves Disease
Sponsors & Collaborators
-
Shandong Provincial Hospital
lead OTHER_GOV
Principal Investigators
-
Haiqing Zhang · Shandong Provincial Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-15
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- China
Study Locations
More Related Trials
-
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
NCT05678374 ·Status: RECRUITING
-
Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients
NCT01534169 ·Status: COMPLETED ·Phase: PHASE1
-
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
NCT06081439 ·Status: RECRUITING
-
HIFU vs RAI in the Relapsed Graves' Disease
NCT03013257 ·Status: COMPLETED ·Phase: NA
-
Intestinal Microbiota and Treatment of GD
NCT03433352 ·Status: UNKNOWN
-
Post-Radioiodine Graves' Management: The PRAGMA-Study
NCT01885533 ·Status: COMPLETED
-
TSI and Its Relationship With Graves' Disease Relapse
NCT05713097 ·Status: COMPLETED
-
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
NCT06426758 ·Status: NOT_YET_RECRUITING
-
Natural History of Thyroid Function Disorders
NCT00001159 ·Status: RECRUITING
-
Incidence of Graves' Disease After COVID-19 Vaccination
NCT07213141 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
NCT02713256 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in the Treatment of Graves' Disease
NCT00150111 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DNA Methylation and Autoimmune Thyroid Diseases
NCT02491567 ·Status: COMPLETED
-
TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease
NCT00335062 ·Status: COMPLETED
-
Thyroid Disease and Personality Study
NCT02620085 ·Status: UNKNOWN
-
Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient?
NCT01247077 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases
NCT04075851 ·Status: UNKNOWN
-
Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves' Disease
NCT00505011 ·Status: COMPLETED
-
Low-dose Radioiodine Ablation in Graves' Disease
NCT03110835 ·Status: COMPLETED
-
Evaluation of Thyroid Function in Patients With Chronic Kidney Disease
NCT04658524 ·Status: ACTIVE_NOT_RECRUITING
-
Cardiac Symptoms in Patients With Treated Graves' Disease
NCT06908369 ·Status: ACTIVE_NOT_RECRUITING
-
Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients
NCT02993302 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
NCT03498417 ·Status: COMPLETED